Outpatient Administration of Blinatumomab Infusion and Hematopoietic Stem Cell Transplantation as Treatment for Patients with Refractory Acute Lymphoblastic Leukemia in a Pediatric Oncologic Center in Mexico.
Godoy-Fernández JF1, Pilar-Cubría MP2, Zapata-Tarrés M3, Taveras-Rodríguez Omageline 4, Briseño-Rebollar EV5, Bautista-Hernández I6, Vega-Vega L7, Bernabé-Gaspar Luis Eduardo8, Pérez-García M9.
1.Resident of the pediatric program for hematopoietic stem cell transplantation, Hospital Infantil Teleton de Oncologia. México.godoy@hospitalteleton.org.mx
2. Chief of the Acute Lymphoblastic Leukemia Department, Hospital Infantil Teleton de Oncologia. México.cubria@hospitalteleton.org.mx
3. Research Coordination, Mexican Institute of Social Services Foundation, Fundación IMSS. Mexico.marta.zapata@fundacionimss.org.mx
4.Resident of the pediatric program for hematopoietic stem cell transplantation, Hospital Infantil Teleton de Oncologia. México.taveras@hospitalteleton.org.mx
5. Department of hematopoietic stem cell transplantation, Hospital Infantil Teleton de Oncologia. México.briseno@hospitalteleton.org.mx
6. Chief of the Oncologic Surgery Department, Hospital Infantil Teleton de Oncologia. México.ibautista@hospitalteleton.org.mx
7. Director, Hospital Infantil Teletón de Oncología. México.vega@hospitalteleton.org.mx
8. Faculty of Medicine, Benemérita Universidad Autónoma de Puebla.luis.bernabe@alumno.buap.mx
9. Chief of the hematopoietic cell stem transplantation Department, Hospital Infantil Teleton de Oncologia. México.mperezg@hospitalteleton.org.mx
Corresponding Author: Martín Pérez García
Address: Anillo Vial Fray Junípero Serra 1999, Rancho Menchaca, 76140 Santiago de Querétaro, Querétaro. México.
Phone: +52 5514843680
email:mperezg@hospitalteleton.org.mx